Neurotoxic potentiation is related to a metabolic interaction between p- bromophenylacetylurea and phenylmethanesulfonyl fluoride

Toxicology and Applied Pharmacology

Volumn 157, Issue 3, 1999, Pages 222-226

  Xu, Jinsheng ^a   Lister, Timothy ^b   Purcell, Wendy M ^a   Ray, David E ^b  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 BROMOPHENYLACETYLUREA; BENZYLSULFONYL FLUORIDE; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; BODY WEIGHT; CONTROLLED STUDY; DRUG ELIMINATION; DRUG METABOLISM; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROPATHY; NEUROTOXICITY; NONHUMAN; RAT; TARGET ORGAN;

EID: 0033564424     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8680     Document Type: Article

References (14)

1. Abou-Donia M. B., Wilmarth K. R., Jensen K. F., Oehme F. W., Kurt T. L. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin-implications of Gulf-War chemical exposures. J. Toxicol. Environ. Health. 48:1996;35-56.
2. Cavanagh J. B., Chen F. C-K. The experimental neuropathy in rats caused by p-bromophenylacetylurea. J. Neurosurg. Psych. 31:1968;471-478.
3. Diezel P. B., Quadbeck G. Nervenschadigung durch p-bromophenylacetyl-harnstoff. Naunyn Schmiedeberg's Arch. Pharmakol. Exp. Pathol. 238:1960;534-541.
4. Fioroni F., Morretto A., Lotti M. Triphenylphosphite neuropathy in hens. Archiv. Toxicol. 69:1995;705-711.
5. Johnson M. K., Lauwerys R. Protection by some carbomates against the delayed neurotoxic effects of diisopropyl phosphorofluoridate. Nature. 222:1969;1066-1067.
6. Johnson M. K., Ray D. E. Evaluation of phenylmethanesulphonyl fluoride as a promoter of peripheral neuropathies in the rat. Hum. Exp. Toxicol. 11:1992;421-422.
7. Lotti M., Caroldi S., Capodicasa E., Moretto A. Promotion of organophosphate-induced polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol. Appl. Pharmacol. 108:1991;234-241.
8. Osman K. A., Moretto A., Lotti M. Sulfonyl fluorides and the promotion of diisopropyl fluorophosphate neuropathy. Fundam. Appl. Toxicol. 33:1996;294-297.
9. Pope C. N., Padilla S. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethanesulfonyl floride. J. Toxicol. Environ. Health. 31:1990;261-273.
10. Pope C. N., Chapman M. L., Tanaka J. R., Padilla S. Phenylmethanesulfonyl fluoride alerts sensitivity to organophosphorus-induced delayed neurotoxicity in developing animals. Neurotoxicology. 13:1992;355-364.
11. Sipes I. G., Gandolfi A. J. Biotransformation of toxicants. Amdur M. O. Casarett and Doll's Toxicology- The Basic Science of Poisons. 1991;88-105 McGraw-Hill Inc. New York.
12. Sprent P. Three or more samples. Applied Nonparametric Statistical Methods. 1993;Chapman & Hall, London. p. 132-151.
13. Veronesi B., Padilla S. Phenylmethanesulfonyl fluoride protects rats from mipafox-induced delayed neuropathy. Toxicol. Appl. Pharmacol. 81:1985;258-264.
14. Xu, J.1998. Metabolism and pharmacokinetic factors in p-bromophenylacetylurea-induced neuropathy. In Ph.D. Thesis: Pharmacokinetic Factors in the Neurotoxicities of p-Bromophenylacetylurea and m-Dinitrobenzene (J. Xu), pp. 40-102. MRC Toxicoloty Unit, Leicester.